Events Partner Content The Pharma Forecasting Workshop - Fundamentals of Forecastin... J+D Interactive Pharma Forecasting Workshop
Events Partner Content The Pharma Forecasting Workshop - Fundamentals of Forecastin... The Fundamentals of Forecasting with J+D
Partner Content Partner Content J+D, Pharma Forecasting Experts Partner with Epiphany, Oncol... J+D have brought several innovations to market this year including Online Training, th
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.